An experimental Alzheimer’s drug from Eli Lilly showed significant slowing of decline in patients with early symptoms of the disease, the company said Monday.The results from a small clinical trial have not been published in a peer-reviewed journal…
Copyright © 2024 | WordPress Theme by MH Themes